HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells.

AbstractBACKGROUND/AIM:
B cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is up-regulated in several cancers; therefore, we investigated the effects of BMI1 inhibitors on leukemia cells.
MATERIALS AND METHODS:
Four acute myeloid leukemia and two T-lymphoblastic leukemia cell lines were treated with BMI1 inhibitors artemisinin, PRT4165, and PTC-209 and analyzed for cell proliferation and gene expression by microarray and immunoblotting.
RESULTS:
PTC-209 and PRT4165 suppressed the growth of all cell lines through apoptosis.Artemisinin acted only on Jurkat cells. BMI1 inhibitors and BMI1-specific siRNA down-regulated the expression of NOTCH signaling proteins NOTCH1, HES1, and MYC. All but one cell lines did not have the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene targeted by BMI1, thus the inhibitors acted through CDKN2A-independent pathways.
CONCLUSION:
BMI1 inhibition suppressed proliferation of leukemia cells through NOTCH signaling which functions downstream of BMI1, suggesting that BMI1 inhibitors can be candidate targeted drugs against leukemia.
AuthorsMika Ohtaka, Mai Itoh, Shuji Tohda
JournalAnticancer research (Anticancer Res) Vol. 37 Issue 11 Pg. 6047-6053 (11 2017) ISSN: 1791-7530 [Electronic] Greece
PMID29061784 (Publication Type: Journal Article)
CopyrightCopyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Chemical References
  • BMI1 protein, human
  • Heterocyclic Compounds, 2-Ring
  • PTC-209
  • RNA, Small Interfering
  • Receptors, Notch
  • Thiazoles
  • Polycomb Repressive Complex 1
Topics
  • Apoptosis (drug effects)
  • Cell Proliferation (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Heterocyclic Compounds, 2-Ring (pharmacology)
  • Humans
  • Leukemia, Myeloid, Acute (drug therapy, metabolism, pathology)
  • Leukemia, T-Cell (drug therapy, metabolism, pathology)
  • Polycomb Repressive Complex 1 (antagonists & inhibitors, genetics, metabolism)
  • RNA, Small Interfering (genetics)
  • Receptors, Notch (antagonists & inhibitors, genetics, metabolism)
  • Signal Transduction (drug effects)
  • Thiazoles (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: